Home › No longer valid
Codes that are no longer valid
A code can be refused for three different reasons, and they have three different fixes. Every code that was ever valid for billing keeps its page on this site rather than disappearing, so a rejected code can always be looked up.
It exists, but cannot be submitted on its own
A category header groups more specific codes. The fix is to code to the level of detail the chart supports, using one of its children - which that code's own page lists.
- ICD-10-CM 23,524
- ICD-10-PCS 918
It has been removed from the code set
Usually because the publisher subdivided it into more specific codes. The replacement is recorded in the publisher's own conversion table, and is shown on the retired code's page.
- ICD-10-CM 682
- ICD-10-PCS 3,257
It carries a termination date
HCPCS works differently from ICD-10: CMS never removes a code from the quarterly file. It keeps the row and fills in a termination date, so a dead HCPCS code is still listed and still looks current at a glance. That is why a "deleted HCPCS codes" list built the way an ICD-10 one is built comes back permanently empty.
- HCPCS Level II 1,322
- HCPCS modifier 20
Most recently stopped being valid
The codes most likely to be in circulation on an old claim or a stale cheat sheet.
| Code | Description | Last valid |
|---|---|---|
| 30233AZ | Transfusion of Embryonic Stem Cells into Peripheral Vein, Percutaneous Approach ICD-10-PCS | FY2026 |
| 30243AZ | Transfusion of Embryonic Stem Cells into Central Vein, Percutaneous Approach ICD-10-PCS | FY2026 |
| S23.420 | Sprain of sternoclavicular (joint) (ligament) ICD-10-CM | FY2026 |
| S23.420A | Sprain of sternoclavicular (joint) (ligament), initial encounter ICD-10-CM | FY2026 |
| S23.420D | Sprain of sternoclavicular (joint) (ligament), subsequent encounter ICD-10-CM | FY2026 |
| S23.420S | Sprain of sternoclavicular (joint) (ligament), sequela ICD-10-CM | FY2026 |
| T52.8X | Toxic effects of other organic solvents ICD-10-CM | FY2026 |
| T52.8X1 | Toxic effect of other organic solvents, accidental (unintentional) ICD-10-CM | FY2026 |
| T52.8X1A | Toxic effect of other organic solvents, accidental (unintentional), initial encounter ICD-10-CM | FY2026 |
| T52.8X1D | Toxic effect of other organic solvents, accidental (unintentional), subsequent encounter ICD-10-CM | FY2026 |
| T52.8X1S | Toxic effect of other organic solvents, accidental (unintentional), sequela ICD-10-CM | FY2026 |
| T52.8X2 | Toxic effect of other organic solvents, intentional self-harm ICD-10-CM | FY2026 |
| T52.8X2A | Toxic effect of other organic solvents, intentional self-harm, initial encounter ICD-10-CM | FY2026 |
| T52.8X2D | Toxic effect of other organic solvents, intentional self-harm, subsequent encounter ICD-10-CM | FY2026 |
| T52.8X2S | Toxic effect of other organic solvents, intentional self-harm, sequela ICD-10-CM | FY2026 |
| T52.8X3 | Toxic effect of other organic solvents, assault ICD-10-CM | FY2026 |
| T52.8X3A | Toxic effect of other organic solvents, assault, initial encounter ICD-10-CM | FY2026 |
| T52.8X3D | Toxic effect of other organic solvents, assault, subsequent encounter ICD-10-CM | FY2026 |
| T52.8X3S | Toxic effect of other organic solvents, assault, sequela ICD-10-CM | FY2026 |
| T52.8X4 | Toxic effect of other organic solvents, undetermined ICD-10-CM | FY2026 |
| T52.8X4A | Toxic effect of other organic solvents, undetermined, initial encounter ICD-10-CM | FY2026 |
| T52.8X4D | Toxic effect of other organic solvents, undetermined, subsequent encounter ICD-10-CM | FY2026 |
| T52.8X4S | Toxic effect of other organic solvents, undetermined, sequela ICD-10-CM | FY2026 |
| X2KB317 | Bypass Right Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| X2KC317 | Bypass Left Radial Artery using Thermal Resistance Energy, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XD2 | New Technology, Gastrointestinal System, Monitoring ICD-10-PCS | FY2026 |
| XD2G4V7 | Monitoring of Upper GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XD2G8V7 | Monitoring of Upper GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 ICD-10-PCS | FY2026 |
| XD2H4V7 | Monitoring of Lower GI Oxygen Saturation, Percutaneous Endoscopic Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XD2H8V7 | Monitoring of Lower GI Oxygen Saturation, Via Natural or Artificial Opening Endoscopic, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGA0R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGA3R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGA4R7 | Fusion of Thoracolumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGB0R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGB3R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGB4R7 | Fusion of Lumbar Vertebral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGC0R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGC3R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGC4R7 | Fusion of 2 or more Lumbar Vertebral Joints using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGD0R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Open Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGD3R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XRGD4R7 | Fusion of Lumbosacral Joint using Custom-Made Anatomically Designed Interbody Fusion Device, Percutaneous Endoscopic Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW00X27 | Introduction of Anacaulase-bcdb into Skin, External Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW01397 | Introduction of Satralizumab-mwge into Subcutaneous Tissue, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW01X27 | Introduction of Anacaulase-bcdb into Subcutaneous Tissue, External Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW023X7 | Introduction of Tixagevimab and Cilgavimab Monoclonal Antibody into Muscle, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW03367 | Introduction of Terlipressin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW03377 | Introduction of Trilaciclib into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW03387 | Introduction of Lurbinectedin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW033B7 | Introduction of Amivantamab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW04367 | Introduction of Terlipressin into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW04377 | Introduction of Trilaciclib into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW04387 | Introduction of Lurbinectedin into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW043B7 | Introduction of Amivantamab Monoclonal Antibody into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW0DXR7 | Introduction of Fostamatinib into Mouth and Pharynx, External Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW0G7R7 | Introduction of Fostamatinib into Upper GI, Via Natural or Artificial Opening, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW0H7R7 | Introduction of Fostamatinib into Lower GI, Via Natural or Artificial Opening, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW133D7 | Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |
| XW133F8 | Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8 ICD-10-PCS | FY2026 |
| XW143D7 | Transfusion of High-Dose Intravenous Immune Globulin into Central Vein, Percutaneous Approach, New Technology Group 7 ICD-10-PCS | FY2026 |